<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04068389</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX 2008/04</org_study_id>
    <nct_id>NCT04068389</nct_id>
  </id_info>
  <brief_title>Ultrafine Particles and Fetal Contamination</brief_title>
  <acronym>FOETOPUF</acronym>
  <official_title>Study of the Permeability of Atmospheric Particles Placenta (Fine and Ultrafine Particles): Analysis of Fetal Retention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the transplacental passage of fine and ultrafine
      particles (nanoparticles) inhaled by the mother.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Epidemiological studies have demonstrated the harmful effects of particulate air pollution on
      the progress of pregnancy and postnatal health.

      Experimental studies have suggested the transplacental passage of asbestos fibers, but
      despite the strong growth in the use and production of fine and ultrafine particles, no study
      has examined the permeability of the placenta to these compounds or the exposures fetuses
      that may result.

      The objective of this study is to evaluate the transplacental passage of fine and ultrafine
      particles (nanoparticles) inhaled by the mother.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 22, 2009</start_date>
  <completion_date type="Actual">November 9, 2012</completion_date>
  <primary_completion_date type="Actual">November 9, 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of fine particles in fetal lung samples yes/no</measure>
    <time_frame>At the screening</time_frame>
    <description>Analysis in electron microscopy</description>
  </primary_outcome>
  <enrollment type="Actual">62</enrollment>
  <condition>Lung; Premature</condition>
  <condition>Pollution; Exposure</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pulmonary Tissue Collection</intervention_name>
    <description>Pulmonary Tissue Collection</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Fetal lung samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Women with a medical termination of pregnancy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - All women volunteers for whom a medical termination of pregnancy is proposed for a fetus
        older than 22 weeks (weight over 500g).

        Exclusion Criteria:

          -  Refusal of participation of the patient.

          -  Fetus with malformation syndrome affecting pulmonary perfusion.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Pregnacy women</gender_description>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Olivia OCHRYMCZUK, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Bordeaux</affiliation>
  </overall_official>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 23, 2019</study_first_submitted>
  <study_first_submitted_qc>August 23, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2019</study_first_posted>
  <last_update_submitted>August 26, 2019</last_update_submitted>
  <last_update_submitted_qc>August 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Atmospheric particles</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

